» Authors » Richard J Schilling

Richard J Schilling

Explore the profile of Richard J Schilling including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 187
Citations 2676
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ahluwalia N, Hussain A, Providencia R, Schilling R
Arrhythm Electrophysiol Rev . 2025 Feb; 14:e02. PMID: 40017669
Background: Left ventricular systolic dysfunction (LVSD) can improve after catheter ablation (CA) in many patients with AF. However, prospective prediction of response can be challenging. The aim of this study...
2.
Ahluwalia N, Bruce D, Ashdown A, Focacci F, Abbass H, Honarbakhsh S, et al.
J Cardiovasc Electrophysiol . 2025 Feb; PMID: 39980449
Background: Exercise Oscillatory Ventilation (EOV) and a steep ventilatory efficiency (VE/VCO2) slope are features of ventilatory inefficiency on cardiopulmonary exercise testing (CPET), both associated with poor prognosis in patients with...
3.
4.
Ahluwalia N, Honarbakhsh S, Joshi A, Abbass H, Chow A, Dhinoja M, et al.
JACC Clin Electrophysiol . 2024 Dec; 11(2):282-294. PMID: 39665707
Background: Patients with reduced left ventricular ejection fraction (LVEF) and rate-controlled atrial fibrillation (AF) may improve after restoring sinus rhythm. This may be due to the elimination of the short...
5.
Ahluwalia N, Honarbakhsh S, Abbass H, Joshi A, Chow A, Dhinoja M, et al.
Open Heart . 2024 Nov; 11(2). PMID: 39608861
Introduction: Atrial fibrillation (AF)-induced cardiomyopathy (AIC) is retrospectively defined after normalisation of left ventricular ejection fraction (LVEF) in sinus rhythm. It is unclear why some patients develop AIC. Hypothesis: Patients...
6.
Ahluwalia N, Majumder S, Koehler J, Landman S, Sarkar S, Schilling R
J Cardiovasc Electrophysiol . 2024 Sep; 35(12):2273-2279. PMID: 39233390
Introduction: Not all patients experience debilitating symptoms during Atrial Fibrillation (AF), some are asymptomatic. The reasons for this inter- and intrasubject variability is unknown. Purpose: The study objective was NOAH...
7.
Providencia R, Ali H, Creta A, Barra S, Kanagaratnam P, Schilling R, et al.
Eur Heart J Open . 2024 Aug; 4(4):oeae058. PMID: 39143978
Aims: Catheter ablation is the most effective rhythm-control option in patients with atrial fibrillation (AF) and is currently considered an option mainly for improving symptoms. We aimed to assess the...
8.
Ahluwalia N, Koehler J, Sarkar S, Vasudevan N, Majumder S, Landman S, et al.
Circ Arrhythm Electrophysiol . 2024 Jun; 17(8):e012842. PMID: 38939945
Background: Atrial fibrillation (AF) events in cardiac implantable electronic devices (CIEDs) are temporally associated with stroke risk. This study explores temporal differences in AF burden associated with HF hospitalization risk...
9.
Papageorgiou N, Sohrabi C, Bakogiannis C, Tsarouchas A, Kukendrarajah K, Matiti L, et al.
Sci Rep . 2024 Apr; 14(1):8371. PMID: 38600217
Cardiac resynchronisation therapy (CRT) improves prognosis in patients with heart failure (HF) however the role of ABO blood groups and Rhesus factor are poorly understood. We hypothesise that blood groups...
10.
MacLean E, Mahtani K, Honarbakhsh S, Butcher C, Ahluwalia N, Dennis A, et al.
Circ Arrhythm Electrophysiol . 2024 Jan; 17(3):e012446. PMID: 38258308
Background: Antimicrobial envelopes reduce the incidence of cardiac implantable electronic device infections, but their cost restricts routine use in the United Kingdom. Risk scoring could help to identify which patients...